Many airway diseases in children, notably bronchiolitis, cystic fibrosis (CF), non-CF bronchiectasis including primary ciliary dyskinesia, pneumonia, and severe asthma are associated with retention of airway secretions. Medications to improve secretions clearance, the mucoactive medications, are employed to treat these diseases with varying degrees of success. This manuscript reviews evidence for the use of these medications and future directions of study
Pathogenetic mechanisms of mucociliary clearance disorders at respiratory pathology in children had ...
<em>A problem of rehabilitation of frequently ailing children (FAC) is one of the actual problems in...
Summary. Chronic airways infection is associated with the greatest morbidity and mortality of patien...
Contains fulltext : 52072.pdf (publisher's version ) (Closed access)Mucoactive age...
Summary. Mucoactive agents are used to treat a variety of lung diseases involving impaired mucocilia...
The paper gives a detailed review of the updates available in the literature on the specific feature...
BackgroundCurrently, there are no guidelines or consensus statements about the usage of inhaled muco...
Abstract Non-cystic fibrosis bronchiectasis (nCFb) is an acquired condition of variable etiology. M...
Introduction. Mucolytic drugs are included in treatment standards and clinical guidelines for the ma...
The article highlights the treatment of the respiratory tract diseases accompanied by the developmen...
This European Respiratory Society task force has reviewed the evidence for paediatric medicines in r...
Chronic airway diseases like cystic fibrosis, chronic bronchitis, asthma, diffuse panbronchiolitis, ...
Practically in all the cases of broncho-pulmonary system diseases, including acute bronchitis, the c...
Mucolytic agents are well known and frequently prescribed drugs in children with different respirato...
Common symptoms of chronic suppurative lung disease or bronchiectasis in children and adolescents ar...
Pathogenetic mechanisms of mucociliary clearance disorders at respiratory pathology in children had ...
<em>A problem of rehabilitation of frequently ailing children (FAC) is one of the actual problems in...
Summary. Chronic airways infection is associated with the greatest morbidity and mortality of patien...
Contains fulltext : 52072.pdf (publisher's version ) (Closed access)Mucoactive age...
Summary. Mucoactive agents are used to treat a variety of lung diseases involving impaired mucocilia...
The paper gives a detailed review of the updates available in the literature on the specific feature...
BackgroundCurrently, there are no guidelines or consensus statements about the usage of inhaled muco...
Abstract Non-cystic fibrosis bronchiectasis (nCFb) is an acquired condition of variable etiology. M...
Introduction. Mucolytic drugs are included in treatment standards and clinical guidelines for the ma...
The article highlights the treatment of the respiratory tract diseases accompanied by the developmen...
This European Respiratory Society task force has reviewed the evidence for paediatric medicines in r...
Chronic airway diseases like cystic fibrosis, chronic bronchitis, asthma, diffuse panbronchiolitis, ...
Practically in all the cases of broncho-pulmonary system diseases, including acute bronchitis, the c...
Mucolytic agents are well known and frequently prescribed drugs in children with different respirato...
Common symptoms of chronic suppurative lung disease or bronchiectasis in children and adolescents ar...
Pathogenetic mechanisms of mucociliary clearance disorders at respiratory pathology in children had ...
<em>A problem of rehabilitation of frequently ailing children (FAC) is one of the actual problems in...
Summary. Chronic airways infection is associated with the greatest morbidity and mortality of patien...